| abstract |
The invention relates to the use of acylglycerophospholipids, in particular of hydrogenated acylglycerophospholipids and of phospholipids with a high ω-3 fatty acid content, for the production of a medicament for the treatment of cancer accompanying symptoms, in particular for the treatment of tumor cachexia, cancerous moods and pains, and for the prophylaxis of tumor growth and metastasis. |